Shahram Salek-Ardakani
No más puestos en curso
Perfil
Shahram Salek-Ardakani held the position of Senior Director-Cancer Immunology at Pfizer Inc. He also worked as an Associate Professor at the University of Florida College of Medicine.
Currently, he is serving as the Chief Scientific Officer at Janux Therapeutics, Inc. from 2021 to 2023.
Antiguos cargos conocidos de Shahram Salek-Ardakani.
| Empresas | Cargo | Fin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/11/2023 |
| University of Florida College of Medicine | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
8
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Shahram Salek-Ardakani
